92 related articles for article (PubMed ID: 9190984)
21. First trimester levels of inhibins and activin A in normal and failing pregnancies.
Wallace EM; Marjono B; Tyzack K; Tong S
Clin Endocrinol (Oxf); 2004 Apr; 60(4):484-90. PubMed ID: 15049964
[TBL] [Abstract][Full Text] [Related]
22. Inhibin-B and pro-alphaC-containing inhibins in amniotic fluid from chromosomally normal and Down syndrome pregnancies.
Wallace EM; Crossley JA; Riley SC; Balfour C; Groome NP; Aitken DA
Prenat Diagn; 1998 Mar; 18(3):213-7. PubMed ID: 9556037
[TBL] [Abstract][Full Text] [Related]
23. Highly specific and sensitive rise in Days 14-17 pro-alphaC inhibin with clinical pregnancy after frozen embryo transfer with ovulatory cycles.
Tong S; Rombauts L; Onwude J; Marjono B; Wallace EM
Hum Reprod; 2007 Aug; 22(8):2249-53. PubMed ID: 17545687
[TBL] [Abstract][Full Text] [Related]
24. Serum inhibin A, inhibin B, and pro-alphaC levels are altered after surgically or pharmacologically induced menopause.
Cobellis L; Luisi S; Pezzani I; Reis FM; De Leo V; Petraglia F
Fertil Steril; 2002 Apr; 77(4):745-9. PubMed ID: 11937127
[TBL] [Abstract][Full Text] [Related]
25. Inhibin as a marker for granulosa-cell tumors.
Lappöhn RE; Burger HG; Bouma J; Bangah M; Krans M; de Bruijn HW
N Engl J Med; 1989 Sep; 321(12):790-3. PubMed ID: 2770810
[TBL] [Abstract][Full Text] [Related]
26. Preoperative serum level of inhibin A is an independent prognostic factor for the survival of postmenopausal women with epithelial ovarian carcinoma.
Frias AE; Li H; Keeney GL; Podratz KC; Woodruff TK
Cancer; 1999 Jan; 85(2):465-71. PubMed ID: 10023716
[TBL] [Abstract][Full Text] [Related]
27. Altered serum profile of inhibin B, Pro-alphaC and anti-Müllerian hormone in prepubertal and pubertal boys with varicocele.
Trigo RV; Bergadá I; Rey R; Ballerini MG; Bedecarrás P; Bergadá C; Gottlieb S; Campo S
Clin Endocrinol (Oxf); 2004 Jun; 60(6):758-64. PubMed ID: 15163341
[TBL] [Abstract][Full Text] [Related]
28. Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer.
Baron AT; Cora EM; Lafky JM; Boardman CH; Buenafe MC; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):103-13. PubMed ID: 12582019
[TBL] [Abstract][Full Text] [Related]
29. Plasma FSH, inhibin A and inhibin isoforms containing pro- and -alphaC during winter anoestrus, spring transition and the breeding season in mares.
Watson ED; Heald M; Tsigos A; Leask R; Steele M; Groome NP; Riley SC
Reproduction; 2002 Apr; 123(4):535-42. PubMed ID: 11914116
[TBL] [Abstract][Full Text] [Related]
30. Serum inhibin pro-αC is a tumor marker for adrenocortical carcinomas.
Hofland J; Feelders RA; van der Wal R; Kerstens MN; Haak HR; de Herder WW; de Jong FH
Eur J Endocrinol; 2012 Feb; 166(2):281-9. PubMed ID: 22127493
[TBL] [Abstract][Full Text] [Related]
31. Serum inhibin and disease status in women with ovarian granulosa cell tumors.
Boggess JF; Soules MR; Goff BA; Greer BE; Cain JM; Tamimi HK
Gynecol Oncol; 1997 Jan; 64(1):64-9. PubMed ID: 8995549
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical expression of inhibin/activin subunits in epithelial and granulosa cell tumours of the ovary.
Arora DS; Cooke IE; Ganesan TS; Ramsdale J; Manek S; Charnock FM; Groome NP; Wells M
J Pathol; 1997 Apr; 181(4):413-8. PubMed ID: 9196439
[TBL] [Abstract][Full Text] [Related]
33. Inhibins and ovarian cancer.
Robertson DM; Pruysers E; Burger HG; Jobling T; McNeilage J; Healy D
Mol Cell Endocrinol; 2004 Oct; 225(1-2):65-71. PubMed ID: 15451569
[TBL] [Abstract][Full Text] [Related]
34. Characterization of inhibin immunoreactivity in post-menopausal women with ovarian tumours.
Burger HG; Robertson DM; Cahir N; Mamers P; Healy DL; Jobling T; Groome N
Clin Endocrinol (Oxf); 1996 Apr; 44(4):413-8. PubMed ID: 8706307
[TBL] [Abstract][Full Text] [Related]
35. Impact of obesity and leptin levels on the secretion of estradiol, inhibin A and inhibin B during ovarian stimulation with gonadotropins.
Urbancsek J; Fedorcsák P; Klinga K; Dévényi N; Papp Z; Rabe T; Strowitzki T
Gynecol Endocrinol; 2002 Aug; 16(4):285-92. PubMed ID: 12396557
[TBL] [Abstract][Full Text] [Related]
36. Secretion of activin A in recurrent epithelial ovarian carcinoma.
Lambert-Messerlian GM; DePasquale SE; Maybruck WM; Steinhoff MM; Gajewski WH
Gynecol Oncol; 1999 Jul; 74(1):93-7. PubMed ID: 10385557
[TBL] [Abstract][Full Text] [Related]
37. Granulosa cell tumors of the ovary: the clinical value of serum inhibin A and B levels in a large single center cohort.
Mom CH; Engelen MJ; Willemse PH; Gietema JA; ten Hoor KA; de Vries EG; van der Zee AG
Gynecol Oncol; 2007 May; 105(2):365-72. PubMed ID: 17306349
[TBL] [Abstract][Full Text] [Related]
38. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer.
Zheng W; Luo MP; Welt C; Lambert-Messerlian G; Sung CJ; Zhang Z; Ying SY; Schneyer AL; Lauchlan SC; Felix JC
Gynecol Oncol; 1998 Apr; 69(1):23-31. PubMed ID: 9570994
[TBL] [Abstract][Full Text] [Related]
39. The testis as a major source of circulating inhibins in the male equine fetus during the second half of gestation.
Tanaka Y; Taniyama H; Tsunoda N; Shinbo H; Nagamine N; Nambo Y; Nagata S; Watanabe G; Herath CB; Groome NP; Taya K
J Androl; 2002; 23(2):229-36. PubMed ID: 11868816
[TBL] [Abstract][Full Text] [Related]
40. [Serum level and expression of vascular epithelial growth factor in ovarian epithelial carcinoma].
Sun LX; Wu Y; Han HQ; Wang QH
Ai Zheng; 2003 Jan; 22(1):58-61. PubMed ID: 12561438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
